These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An update on HDV: virology, pathogenesis and treatment. Alvarado-Mora MV, Locarnini S, Rizzetto M, Pinho JR. Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471 [Abstract] [Full Text] [Related]
3. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances]. Romeo R. Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000 [Abstract] [Full Text] [Related]
13. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction. Suárez-Amarán L, Usai C, Di Scala M, Godoy C, Ni Y, Hommel M, Palomo L, Segura V, Olagüe C, Vales A, Ruiz-Ripa A, Buti M, Salido E, Prieto J, Urban S, Rodríguez-Frias F, Aldabe R, González-Aseguinolaza G. J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664 [Abstract] [Full Text] [Related]
17. Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China. Shen L, Gu Y, Sun L, Yang Y, Wang F, Li Y, Bi S. J Med Virol; 2012 Mar; 84(3):445-9. PubMed ID: 22246830 [Abstract] [Full Text] [Related]
18. Hepatitis delta in HIV-infected individuals in Europe. Soriano V, Grint D, d'Arminio Monforte A, Horban A, Leen C, Poveda E, Antunes F, de Wit S, Lundgren J, Rockstroh J, Peters L. AIDS; 2011 Oct 23; 25(16):1987-92. PubMed ID: 21857493 [Abstract] [Full Text] [Related]